Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth A Prosser

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Nature Chemical Biology|March 24, 2020
D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibitionCesira de Chiara, Miha Homšak, Gareth A Prosser, et al.
Frontiers in Microbiology|December 28, 2020
Development and Optimization of Chromosomally-Integrated Fluorescent <i>Mycobacterium tuberculosis</i> Reporter ConstructsKatharina Kolbe, Alice C Bell, Gareth A Prosser, et al.
Biochemical Pharmacology|February 13, 2013
Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104AGareth A Prosser, Janine N Copp, Alexandra M Mowday, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Nature Chemical Biology|March 24, 2020
D-Cycloserine destruction by alanine racemase and the limit of irreversible inhibitionCesira de Chiara, Miha Homšak, Gareth A Prosser, et al.
Frontiers in Microbiology|December 28, 2020
Development and Optimization of Chromosomally-Integrated Fluorescent <i>Mycobacterium tuberculosis</i> Reporter ConstructsKatharina Kolbe, Alice C Bell, Gareth A Prosser, et al.
Biochemical Pharmacology|February 13, 2013
Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104AGareth A Prosser, Janine N Copp, Alexandra M Mowday, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2026
Identification and Evaluation of dibasic piperidines as novel cell wall inhibitors against <i>Mycobacterium tuberculosis</i>Claire Naylor, Gareth A Prosser, Tracy Bayliss, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Pageof 2